瘤微环境中的pH调节剂及其抑制剂
Senyi Liao1, Guang Wu2, Zhizhong Xie1
1Institute of Pharmacy and Pharmacology, Hunan Provincial Key Laboratory of Tumor Microenvironment Responsive Drug Research, Hengyang Medical School, University of South China, Hengyang, Hunan, 421001, China.
European journal of medicinal chemistry
|February 3, 2024
概括
酸性瘤微环境 (TME) 推动癌症的进展和耐药性. 本综述探讨了pH调节剂,如单碳酸盐载体 (MCT) 和碳酸无水酶IX (CA IX),作为新抗瘤药物的标.
科学领域:
- 在瘤学瘤学.
- 生物化学 生物化学
- 癌症生物学 癌症生物学
背景情况:
- 酸性瘤微环境 (TME) 是癌症的标志,促进免疫逃生,入侵和转移.
- 瘤酸性源于代谢的副产品,如乳酸和CO2.
- 关键的pH调节剂,包括单碳酸盐运输体 (MCT),碳酸无水酶IX (CA IX) 和Na+/H+交换1 (NHE1),维持这种酸性TME.
研究的目的:
- 审查pH调节器在确定酸性TME的关键功能.
- 检查针对这些pH调节器的抑制剂的结构-活性关系.
- 概述开发小分子抗瘤抑制剂的策略,针对pH调节器.
主要方法:
- 在TME中对pH调节剂的文献综述.
- 对pH调节抑制剂的结构和功能数据的分析.
- 对小分子抑制剂的结构-活性关系 (SAR) 的探索.
主要成果:
- pH调节器积极促进瘤酸度和相关的恶性行为.
- 抑制剂的特定结构特征与其疗效相关.
- 了解SAR为合理的药物设计提供了基础.
结论:
- 准pH调节剂提供了对抗癌症的有希望的治疗策略.
- 针对MCT,CA IX和NHE1的小分子抑制剂显示出潜在的抗瘤活性.
- 对抑制剂开发的进一步研究可能会导致新的癌症治疗方法.
相关概念视频
Regulation of Angiogenesis and Blood Supply
2.6K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Receptor Downregulation in MVBs
2.1K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.1K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K


